Improve Medical Instruments Co Ltd
SZSE:300030
Improve Medical Instruments Co Ltd
Net Income (Common)
Improve Medical Instruments Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
Improve Medical Instruments Co Ltd
SZSE:300030
|
Net Income (Common)
-¥80m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Net Income (Common)
¥9.4B
|
CAGR 3-Years
31%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Net Income (Common)
¥1.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Net Income (Common)
¥3.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Net Income (Common)
¥1.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
27%
|
CAGR 10-Years
33%
|
|
Genscript Biotech Corp
HKEX:1548
|
Net Income (Common)
-$95.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Improve Medical Instruments Co Ltd's Net Income (Common)?
Net Income (Common)
-80m
CNY
Based on the financial report for Mar 31, 2024, Improve Medical Instruments Co Ltd's Net Income (Common) amounts to -80m CNY.
What is Improve Medical Instruments Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
10%
Over the last year, the Net Income (Common) growth was 46%.